Alex Ekwueme Federal University Teaching Hospital Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2017
NCT04501289
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Adebayo Joshua Adeniyi | Alex Ekwueme Federal University Teaching Hospital | Alex Ekwueme Federal University Teaching Hospital, Abakaliki

Active Ingredients

Drugs in Phase 2 Trials (1)

tranexamic acid (cyklokapron) (1 trial)

Drugs in Other Trials (3)

hydralazine (apresoline) (1 trial)

magnesium sulfate (Tis-U-Sol) (1 trial)

nifedipine (procardia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hemorrhage (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4